Prostate Cancer

Does PSA screening lead to an overtreatment of prostate cancer? Clayton S. Lau, M.D., discusses the topic.

An expert sat down with CURE to discuss standard therapies for localized prostate cancer.

Robotic surgery is a promising option in the field of prostate cancer, leading to better outcomes and shorter hospital stays.

Androgen deprivation therapy may be linked to dementia in men with prostate cancer, according to a recent study.

Three treatment options for localized prostate cancer all showed a similar low prostate-specific mortality rate.

Choosing active surveillance did not increase stress levels for men with low-risk prostate cancer, according to a recent study.

Does PSA-based prostate cancer screening lead to less deaths from the disease? CURE explores both sides of the debate.

Not all patients with prostate cancer benefit from the same therapies. Here's a look at some of the hormone therapy options available.

With a variety of treatment options for prostate cancer also comes a variety of side effects. Here is a list of potential side effects to discuss with your doctor when deciding on a treatment plan.

After a host of recent advances in the treatment of prostate cancer, the forward push continues as immunotherapy and combinations of older agents are tested in patients.